|
|
Thomson Financial Business Description:
| The Group's principal activity is biopharmaceutical development, specialising in human gene therapy. The Group's therapies utilise a therapeutic gene to correct the underlying genetic defects that cause metabolic disorders, ocular diseases and diseases of the central and peripheral nervous system. The Group is based in the Academic Medical Centre of the University of Amsterdam. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on AMT Holding NV
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
